News for hackers. Stuff that matters.
Re:The Cold-Medicine Racket by smacktoward on Friday December 19, 2014 @01:48PM (#8773754)
I wonder how much of that wasted money could be saved by taking an approach with brand-name drugs similar to the one taken with cigarette packages: require them to carry a big-ass label. Something to the effect of "THIS PRODUCT IS MEDICALLY EQUIVALENT TO [ insert name of generic here ]" in great big, bold type.

Of course that would cut into pharma's profits, so it would never in a million years actually happen.

Re:The Cold-Medicine Racket by MichaelGG on Friday December 19, 2014 @02:05PM (#8773866)
Except generics aren't guaranteed to be equivalent. Indian pharma companies have been incredibly corrupt, outright lying about their products:

http://fortune.com/2013/05/15/dirty-medicine/

I'd be very hesitant about buying medicine from such companies. But I agree that if the regulators could assure quality, then yes, pointing out equivalence would help a lot of people.

Re:The Cold-Medicine Racket by pnathan on Friday December 19, 2014 @02:47PM (#8774099)
Incredible.

Is there a data source for companies & drugs that are known bad?

Re:The Cold-Medicine Racket by refurb on Friday December 19, 2014 @02:51PM (#8774123)
The FDA does a pretty good job of forcing the offending companies to recall the bad product. They even go as far as banning any imports from said companies until they've proven that they have cleaned up their act.
Re:The Cold-Medicine Racket by pnathan on Friday December 19, 2014 @02:57PM (#8774157)
Well... um. Read the Fortune article, and that pretty much invalidates your statement. This particular company was in the middle of an investigation and was still shipping product. Similar situations have occurred in the past (I can't recall names anymore though).

I would love to pull up an app, tap a few buttons, and ask the pharmacist to change the meds to brand name when they are selling me products produced by $sketchy_fraudulent_company.

Re:The Cold-Medicine Racket by refurb on Friday December 19, 2014 @06:16PM (#8775123)
I'm not saying the FDA does a good job of catching this activity early. The only way they find out is either through inspections (they are horribly understaffed) or through product complaints.

When do they find out they drop the hammer. Most (all?) Ranbaxy plants are banned from importing product into the US and many products were recalled.

Re:The Cold-Medicine Racket by MichaelGG on Friday December 19, 2014 @08:02PM (#8775445)
Really? Articles from early 2014 say 4 plants are banned, while Ranbaxy's website boasts 21 manufacturing locations.

Sun Pharma, which is buying (or bought?) Ranbaxy, recently got a plant ban for the same types of issues. (They delete test info if it isn't in their favour, and have terrible hygiene at the labs.) It's obviously endemic. And Sun quickly noted that the ban only affects 1% of their revenue.

It seems unbelievable that this deep level of corruption is exposed, and the FDA does limited bans and recalls. Instead of, say, completely banning the company and high-level individuals involved, until a complete end-to-end audit is completed. It's simply counterfactual to think these limited bans are accomplishing anything, or that a company is going to utterly and completely change the way they conduct themselves from individual techs all the way up to the board.

The Fortune article says none of the FDA inspectors would ever personally buy drugs from Ranbaxy, ban or not.

Re:The Cold-Medicine Racket by refurb on Saturday December 20, 2014 @03:05AM (#8776119)
Articles from early 2014 say 4 plants are banned, while Ranbaxy's website boasts 21 manufacturing locations.

Interesting, I looked it up and yes, the FDA is banning each plant separately. One could argue that the FDA can only ban the plants they find problems at, however, I would agree with you that Ranbaxy's behavior is bad enough to stop all shipments into the US. Not sure why the FDA decided to be more lenient. Maybe the law governing the FDA limits how far it can go? I don't know.

Re:The Cold-Medicine Racket by MichaelGG on Friday December 19, 2014 @03:26PM (#8774305)
No, according to that article, the FDA can only (or only does) ban specific manufacturing facilities. So in Ranbuxy's case, even though it's clear the entire company is totally and utterly corrupt, with contempt for users and disregard for any semblance of proper engineering, they only got a few of their facilities closed. The fact that they were bought by Sun Pharma discredits that entire set of companies.

It's simply not possible to see how such a company can be redeemed; it's rotten to the core.

Re:The Cold-Medicine Racket by mikeash on Friday December 19, 2014 @02:11PM (#8773896)
Are they any less guaranteed than the name brands?
Re:The Cold-Medicine Racket by MichaelGG on Friday December 19, 2014 @02:40PM (#8774052)
The Indian companies had s very hard time getting their EU and American employees to go along with this kind of stuff. From my personal experience in Central America and what I've heard from first person accounts of India and other places in the world, outright corruption and total disregard for safety or QA seems less likely to affect North/Western countries.

I'm trying to phrase that politely, but yes, there seems to be much reason to trust the main name brands over those generic companies.

Re:The Cold-Medicine Racket by mikeash on Friday December 19, 2014 @02:47PM (#8774097)
Are the name brands never manufactured in India and similar places?
Re:The Cold-Medicine Racket by MichaelGG on Friday December 19, 2014 @03:39PM (#8774378)
It seems like they use less Indian plants, and more EU plants, based on some quick searches. But I didn't find a comprehensive list.

But additionally, it's part of corporate culture. In fact, the article I linked to says that Ranbuxy had a manufacturing plant in the US, and that plant ended up making pills containing glass fragments. So it seems more of who is "in charge". That said, I'd trust stuff manufactured by a EU company in a EU location more than manufactured in a less controlled location.

I have noticed that local companies of a global corp will misbehave in incredible ways. And some US companies might not realise just how bad it can get on-site, in country. They are big on deferring things to their local subsidiaries, figuring they know best. For instance, MS has had huge problems with local companies in Latin America. From misrepresenting the success and adoption, to pure outright theft. It's unlikely you'd see the same thing happening on the same scale at MS's North Carolina or Toronto office, for instance -- just because there's a higher chance of someone speaking up.

I'm not saying the US or EU are infallible or better, just that people might not be acutely aware of how "flexible" other countries can be at breaking laws. (And not that I blame "the locals" entirely, the risk/reward is so excellent, in addition to a generally poor background situation, that I'm not sure I'd necessarily do better put in the same position. (Same for crime: If I could pull a gun on someone with low risk of being caught, and make off with several months' salary, it'd be a large temptation if I didn't have steady housing/food/etc.))

Of course, this might be selection bias plus some personal biases I have just poking through.

Re:The Cold-Medicine Racket by refurb on Saturday December 20, 2014 @03:01AM (#8776114)
Of course that would cut into pharma's profits, so it would never in a million years actually happen.

That's a cynically opinion.

When it comes to prescription drugs, most states have generic substitution requirements. That is, if your doctor writes a script for Lipitor, the pharmacist is required to fill it with the generic unless the doctor writes (DAW = dispense as written).

When it comes to OTC drugs, I think it's up to the consumer to educate themselves.